FDA Okays Submicron Diclofenac (Zorvolex) for OsteoarthritisFDA Okays Submicron Diclofenac (Zorvolex) for Osteoarthritis
Zorvolex is now indicated for the management of mild to moderate acute pain and osteoarthritis pain. FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news
More News: Brain | Diclofenac | Neurology | Neurosurgery | Osteoarthritis | Pain | Pain Management | Voltaren